forgemax.FORGED. TESTED. PROVEN.
Anavar 10mg/tab 100 Tabletten by Elbrus Pharmaceuticals
Best seller

Anavar 10mg/tab 100 Tabletten by Elbrus Pharmaceuticals

Elbrus Pharmaceuticals Anavar delivers Oxandrolone at a precisely calibrated 10 mg per tablet in a 100-tablet format engineered for the structured, phase-driven dosing demands of competitive bodybuilding contest preparation. Each tablet's low unit strength gives athletes the granular control that peak-week and final-cut protocols require, allowing day-by-day dose adjustments without tablet splitting or liquid measurement. Quality is enforced at source: every production batch undergoes HPLC potency verification alongside GMP-compliant tablet uniformity testing before release.

€78.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Supports lean-mass retention under a sustained caloric deficit during contest prep
  • 10 mg unit dose enables clean weekly titration aligned with physique response
  • Anti-catabolic action documented in nitrogen-retention studies under hypocaloric conditions
  • No aromatisation pathway — water accumulation risk is not a contest-prep concern
  • 100-tablet count maps directly onto a full 8–10 week competition-preparation block
  • HPLC batch verification ensures declared Oxandrolone content is present in every tablet
  • GMP-manufactured with controlled API sourcing for consistent inter-tablet uniformity

Key takeaways

  • Target 20–30 mg daily for male contest prep, adjusted by weekly physique assessment.
  • Begin Oxandrolone introduction 8–12 weeks before the competition date.
  • Use the 10 mg unit to titrate female prep doses without splitting tablets.
  • Confirm HPLC-verified potency per batch before starting a peak-week protocol.
  • Plan pack quantities ahead: two packs cover a full 8-week male prep at 30 mg.

Oxandrolone as a Contest-Preparation Compound: What the Evidence Shows

Elbrus Pharmaceuticals Anavar is an oral Oxandrolone tablet formulated specifically to serve the dosing architecture that competitive athletes apply during structured pre-contest phases. Contest-prep dosing for Oxandrolone is distinct from off-season use: the objective shifts from tissue accumulation to lean-mass protection under a caloric deficit, and the dose must be titrated accordingly rather than held constant across a bulk. Oxandrolone preserves nitrogen balance during caloric restriction, making it a preferred agent in the 8–16 weeks leading into a competition date.

Competition-Phase Dosing Windows and Practical Ranges

Male competitors typically initiate a contest-prep Oxandrolone protocol between weeks 10 and 12 before the event, starting at 20 mg per day and evaluating muscular fullness, vascularity response, and body-weight trajectory at weekly intervals. Compared to higher-dose legacy approaches that ran 50–80 mg daily throughout a full prep, contemporary evidence-based practice favours a graduated entry — often 20 mg in early prep, 30 mg through the mid-phase, and a maintained or reduced dose in peak week depending on individual water-retention sensitivity. Female competitors follow a substantially lower range: clinical and community outcome data consistently place the effective contest-prep dose between 5 mg and 15 mg per day, with 10 mg representing the single most commonly reported starting point — exactly one tablet of Elbrus Anavar. The 10 mg tablet unit supports this precision; the granularity required for female titration or male step-adjustments is built into the format itself.

Lean-Mass Retention Mechanism During Caloric Deficit

Oxandrolone maintains an anabolic environment through androgen-receptor-mediated upregulation of muscle-protein synthesis even when total caloric intake falls below maintenance. Nitrogen retention studies in hypocaloric subjects confirm that Oxandrolone produces a measurable positive nitrogen balance relative to placebo-treated controls at the same caloric deficit — a mechanistic basis for its anti-catabolic reputation in pre-contest athletes. Elbrus Pharmaceuticals subjects each Anavar batch to HPLC quantification of active Oxandrolone content, with results benchmarked against certified pharmacopoeial reference material, ensuring declared potency is delivered consistently across every tablet in the 100-count container.

Manufacturing Standards Underpinning Contest-Phase Reliability

Tablet uniformity carries particular weight in contest-prep contexts, where a user's weekly dose adjustments depend on each tablet being consistent with the last. Elbrus Pharmaceuticals' API sourcing for this Oxandrolone line prioritises raw-material purity certification at intake, with GMP-validated tablet manufacturing processes controlling compression weight and content uniformity across each production batch. The finished product is packaged in a 100-tablet configuration sized to cover a full 8–10 week contest-prep block without mid-cycle resupply.

Usage

  1. Establish your competition date and count back 8–12 weeks to set the Oxandrolone start date, selecting the opening dose based on experience level: 20 mg for men, 10 mg for women.
  2. Divide the daily dose into two administrations spaced approximately 10–12 hours apart to maintain consistent plasma levels throughout the day without pronounced peaks or troughs.
  3. Take each dose with a meal or immediately after eating to support gastric tolerance; Oxandrolone is generally well tolerated orally but food co-ingestion reduces the likelihood of nausea.
  4. Log weekly body weight, visual fullness, and vascularity response; use these objective markers — not a fixed schedule — to decide whether to advance from 20 mg to 30 mg in the mid-prep phase.
  5. Add liver-support supplementation (e.g. TUDCA or UDCA at evidence-supported doses) throughout the cycle, and schedule an ALT/AST blood panel at baseline and at week 4 to verify hepatic markers remain within acceptable range.
  6. Begin tapering one week before full cessation — reduce by one tablet (10 mg) — then initiate a structured PCT protocol appropriate to any testosterone or other suppressive compounds in the stack, as Oxandrolone itself is suppressive at contest-prep durations.

Warnings

Contraindications: Oxandrolone is contraindicated in individuals with pre-existing hepatic impairment, active or prior androgen-sensitive carcinoma, nephrotic syndrome, or hypercalcaemia. Women who are pregnant or breastfeeding must not use this compound. Patients currently receiving anticoagulant therapy (particularly warfarin) should note that Oxandrolone potentiates anticoagulant activity and requires INR monitoring and likely dose adjustment by a qualified prescriber.

Side Effects: Hepatotoxicity risk is present with all C-17α-alkylated oral compounds including Oxandrolone; elevation of ALT and AST is the primary clinical signal to monitor. Androgenic effects — acne, scalp hair thinning in genetically predisposed individuals, increased facial hair in women — are possible despite Oxandrolone's comparatively low androgenic index. Endogenous testosterone suppression occurs with contest-prep durations and requires PCT to address. Adverse lipid remodelling (LDL elevation, HDL reduction) has been documented in clinical studies and warrants a fasted lipid panel.

Monitoring: Obtain a baseline blood panel before initiating use: ALT, AST, fasting lipid profile, haematocrit, and total testosterone. Repeat liver enzymes at week 4 and at cycle end. Female athletes should monitor closely for early virilisation signs — voice deepening, clitoral enlargement — and discontinue immediately if these emerge, as some virilisation effects may be irreversible.

PCT: Post-cycle therapy is required following Oxandrolone use at contest-prep durations (8–12 weeks). A standard SERM-based protocol (e.g. Nolvadex or Clomid at clinical dosing) should begin within 3–5 days of the final Oxandrolone tablet. Full hypothalamic-pituitary-gonadal axis recovery may take 6–12 weeks post-cessation; bloodwork at week 6 of PCT is recommended to assess progress.

Frequently asked questions

When during a competition prep cycle should Oxandrolone typically be introduced?
Most competitive athletes introduce Oxandrolone 8–12 weeks out from the competition date, once the caloric deficit phase has begun. This window allows sufficient time for the compound to exert its anti-catabolic effect across both the mid-prep and peak-week stages. Starting too early can reduce flexibility for dose escalation if a plateau is encountered in the final weeks.
What dosing range do competitive male bodybuilders use during the final 4 weeks before a show?
Evidence from clinical practice and competitive community reporting places the male contest-prep range at 20–40 mg per day, with most practitioners landing at 30 mg through the mid-phase. In the final 4 weeks, some athletes hold steady or reduce slightly to minimise any stress on liver enzymes ahead of competition day. The 10 mg tablet format allows these adjustments in clean, single-tablet increments.
How does Oxandrolone contest dosing differ between male and female competitors?
Female competitors require substantially lower doses than their male counterparts due to higher baseline sensitivity to anabolic-androgenic compounds. The effective contest-prep range for women typically falls between 5 mg and 15 mg daily, with 10 mg being the most frequently cited starting point in outcome data. Elbrus Anavar's 10 mg unit strength maps directly onto this range without requiring tablet splitting.
Can the 10 mg tablets be split to achieve a 5 mg dose for female athletes?
Yes — the 10 mg tablet format can be split to deliver an approximate 5 mg dose where female athletes or first-cycle users require a sub-10 mg starting point. While GMP tablet manufacturing targets uniform content distribution, athletes requiring a precisely verified 5 mg dose should note that tablet-splitting introduces minor variation and may prefer to source a dedicated lower-strength format if available.
How many tablets does the 100-tablet pack provide for a standard 8-week contest prep block at 30 mg per day?
At 30 mg per day — three tablets — a 100-tablet pack covers approximately 33 days, meaning two packs cover a full 8-week (56-day) contest-prep run with tablets to spare for adjustments. For athletes running 20 mg daily, a single 100-tablet pack extends to a 50-day preparatory window, closely matching the 6–7 week final-cut phase used by many natural and tested competitors. (2) angle_used

Manufacturer

Elbrus Pharmaceuticals' raw material strategy for its oral Oxandrolone line centres on a single upstream principle: API purity at intake is the primary determinant of finished-tablet quality, and it cannot be retrospectively corrected at the tableting stage. The Oxandrolone active pharmaceutical ingredient used in this product is sourced exclusively from suppliers holding valid GMP certification, with each incoming API batch subjected to identity confirmation and purity characterisation before it is cleared for entry into the manufacturing stream. This intake-level control distinguishes batches where content uniformity is built in from the raw material forward, rather than detected — or missed — at end-of-line testing alone. Finished-tablet batches are then assessed by HPLC against certified reference standards to confirm that the 10 mg declared strength corresponds to the actual Oxandrolone content per tablet. The 100-tablet packaging configuration is selected to align with the full duration of a structured contest-prep block, minimising mid-cycle resupply disruption for athletes in a time-sensitive preparation window.

Product details

BrandElbrus Pharmaceuticals
Active ingredientoxandrolone
Also known asAnavar, Oxandrin, Oxandrolone, Elbrus Pharmaceuticals Anavar
Strength10 mg
FormTabletten
Pack size100 pieces
Item numberORA-OXAN-ELB-008

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Oxandrolon 10mg/tab 100 Tablets by Balkan PharmaceuticalsLab Tested

Oxandrolon 10mg/tab 100 Tabletten by Balkan Pharmaceuticals

€52.00
Anavar-Lite 10mg/tab 50 Tablets by Beligas PharmaceuticalsHPLC Verified

Anavar-Lite 10mg/tab 50 Tabletten by Beligas Pharmaceuticals

€48.00
Pro-Anavar 50mg/tab 50 Tablets by Beligas PharmaceuticalsPharma Grade

Pro-Anavar 50mg/tab 50 Tabletten by Beligas Pharmaceuticals

€90.00
OxaTrex 10mg/tab 100 Tablets by Concentrex LabsPurity Tested

OxaTrex 10mg/tab 100 Tabletten by Concentrex Labs

€70.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00